Patient Centricity Vs. Patient Engagement

While patient engagement is critically important, Dr. Anthony Yanni, Vice President at Astellas Pharma, argues that moving the goal to patient centricity is key to advancing patient care. Patient centricity, as Yanni describes an approach where patients, advocates, drug developers, and caregivers all have a dialogue, versus the question and response that typifies patient engagement.

According to Yanni, in an article on Pharma Phorum, “Dialogue means grappling with fundamental issues, such as the importance of improving quality of life while also trying to prolong life, what particular side-effects really are like to live with, which real-world barriers prevent clinical-trial participation, how scientists’ and doctors’ failure to communicate in plain English makes research harder, and so forth. Dialogue requires humility on the drug company’s side—accepting that sometimes we are wrong about matters we think we understand—and trust on the patients’ side that representatives of large, for-profit entities really have come to listen.”

Read the entire article by clicking here.

(Source: Pharma Phorum, December 15^th, 2021)